Company Filing History:
4 out of 205 
3 out of 1,744 
2 out of 2 Years Active: 2018-2025
Title: Giovanni Marsicano: Innovator in Cannabinoid-Related Treatments
Introduction
Giovanni Marsicano is a notable inventor based in Bordeaux, France. He has made significant contributions to the field of cannabinoid-related disorders through his innovative research and patented inventions. With a total of 4 patents, Marsicano's work focuses on developing treatments that target the effects of cannabinoids.
Latest Patents
One of his latest patents is for the compound 3β-(4-methoxybenzyloxy)pregn-5-en-20-one, which is designed for use in the treatment of cannabinoids-related disorders. This invention relates to a specific pregnenolone derivative that has shown potent effects in inhibiting the actions of THC. The compound is particularly effective in reducing both unconditioned and conditioned effects of THC, including THC self-administration and reinstatement in THC-seeking behavior in non-human primates.
Career Highlights
Throughout his career, Giovanni Marsicano has worked with esteemed institutions such as Université de Bordeaux and the Institut National de la Santé et de la Recherche Médicale. His research has been pivotal in advancing the understanding of cannabinoid interactions and their implications for treatment.
Collaborations
Marsicano has collaborated with notable colleagues, including Pier Vincenzo Piazza and Daniela Cota. These partnerships have enriched his research and contributed to the development of innovative solutions in the field.
Conclusion
Giovanni Marsicano's work exemplifies the intersection of innovation and medical research, particularly in the realm of cannabinoid-related disorders. His contributions continue to pave the way for new treatment options and enhance our understanding of cannabinoid effects.